Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: Acute and 3-year outcomes

Journal of Endovascular Therapy

Volumn 11, Issue 6, 2004, Pages 705-711

  Gross, C Michael ^a,b   Schulz Menger, Jeanette ^a   Krämer, Jochen ^a   Siegel, Isabel ^a   Pilz, Bernhard ^a   Waigand, Jürgen ^a   Friedrich, Matthias G ^a   Uhlich, Frank ^a   Dietz, Rainer ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b FRANZ VOLHARD CLINIC   (Germany)

Author keywords

Embolization; Hypertrophic obstructive cardiomyopathy; Polyvinyl alcohol foam particles; Septal ablation; Septal artery

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CONTOUR EMBOLI; POLYVINYL ALCOHOL; SHU 508;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; ATRIOVENTRICULAR BLOCK; CATHETER; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONTROLLED STUDY; DRUG INFUSION; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FLUOROSCOPY; FOAM; FOLLOW UP; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRESSURE GRADIENT; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; WORKLOAD;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; POLYVINYL ALCOHOL; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 12144279149     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/03-1171MR.1     Document Type: Article

References (24)

1. Sigwart U. Nonsurgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211-214.
2. Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation. 1998;98:2415-2421.
3. Gietzen FH, Leuner CJ, Obergassel L, et al. Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions. Circulation. 2002;106:454-459.
4. Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol. 2000;38:1994-2000.
5. Faber L, Meissner A, Ziemssen P, et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients. Heart. 2000;83:326-331.
6. Gietzen FH, Leuner CJ, Raute-Kreinsen U, et al. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J. 1999;20:1342-1354.
7. Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2000;38:1701-1706.
8. Kuhn H, Gietzen FH, Leuner C, et al. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy [in German]. Z Kardiol. 2000;89(Suppl 4):IV41-54.
9. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308-1320.
10. Maron BJ. Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy. Lancet. 2000;355:425-426.
11. Faber L, Seggewiss H, Welge D, et al. Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy [in German]. Z Kardiol. 2003;92:39-47.
12. Siskin GP, Englander M, Stainken BF, et al. Embolic agents used for uterine fibroid embolization. AJR Am J Roentgenol. 2000;175:767-773.
13. Lumsden MA. Embolization versus myomectomy versus hysterectomy: which is best, when? Hum Reprod. 2002;17:253-259.
14. Grindlay JH, Claggett OT. Plastic sponge prosthesis for use after pneumonectomy: preliminary report. Mayo Clin Proc. 1949;24:1538-1539.
15. Payne WS, Kirklin JW. Late complications after plastic reconstruction of outflow tract in tetralogy of Fallot. Ann Surg. 1961;154:53-57.
16. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
17. Schulz-Menger J, Strohm O, Waigand J, et al. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation. 2000;101:1764-1766.
18. Kerber CW, Bank WO, Horton JA, et al. Polyvinyl alcohol foam: prepackaged emboli for therapeutic embolization. AJR Am J Roentgenol. 1978;130:1193-1194.
19. Quisling RG, Mickle JP, Ballinger WB, et al. Histopathologic analysis of intra-atrial polyvinyl alcohol microemboli in rat cerebral cortex. AJNR Am J Neuroradiol. 1984;5:101-104.
20. Germano IM, Davis RL, Wilson CB, et al. Histopathological follow-up study of 66 cerebral arteriovenous malformations after therapeutic embolization with polyvinyl alcohol. J Neurosurg. 1992;76:607-614.
21. Castaneda-Zuniga WR, Sanchez R, Amplatz K. Experimental observation on short and long-term effects of arterial occlusion with Ivalon. Radiology. 1978;126:783-785.
22. Link DP, Strandberg JD, Virmani R, et al. Histopathologic appearance of arterial occlusions with hydrogel and polyvinyl alcohol embolic material in domestic swine. J Vasc Interv Radiol. 1996;7:897-905.
23. Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol. 2001;38:1994-2000.
24. Pelage JP, Laurent A, Wassef M, et al. Uterine artery embolization in sheep: comparison of acute effects with polyvinyl alcohol particles and calibrated microspheres. Radiology. 2002;224:436-445.